While Crispr-Cas9 has drawn a lot of attention, scientists are investigating other Crispr approaches that may reach doctors and patients more quickly.
WSJ.com: Books, Wall Street Journal: Books
Fri, 10/21/2016 - 1:35pm
While Crispr-Cas9 has drawn a lot of attention, scientists are investigating other Crispr approaches that may reach doctors and patients more quickly.